{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:16:42Z","timestamp":1794493002699,"version":"4.9.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-15091-y","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T08:48:50Z","timestamp":1762246130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["UHRF1 and NF-\u03baB signaling in prostate cancer progression insights from bioinformatics and experimental validation"],"prefix":"10.1186","volume":"25","author":[{"given":"Yan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"15091_CR1","doi-asserted-by":"publisher","first-page":"e0247827","DOI":"10.1371\/journal.pone.0247827","volume":"16","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang J, Tang Q, Ren G. Identification of UBE2C as hub gene in driving prostate cancer by integrated bioinformatics analysis. PLoS ONE. 2021;16:e0247827. https:\/\/doi.org\/10.1371\/journal.pone.0247827.","journal-title":"PLoS ONE"},{"key":"15091_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66:115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"CA Cancer J Clin"},{"key":"15091_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","journal-title":"CA Cancer J Clin"},{"key":"15091_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.3233\/CBM-170362","volume":"20","author":"E Fang","year":"2017","unstructured":"Fang E, Zhang X, Wang Q, Wang D. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach. Cancer Biomark. 2017;20:553\u201361. https:\/\/doi.org\/10.3233\/CBM-170362.","journal-title":"Cancer Biomark"},{"key":"15091_CR5","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1126\/science.1147939","volume":"317","author":"M Bostick","year":"2007","unstructured":"Bostick M, et al. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science. 2007;317:1760\u20134. https:\/\/doi.org\/10.1126\/science.1147939.","journal-title":"Science"},{"key":"15091_CR6","doi-asserted-by":"publisher","first-page":"6053","DOI":"10.1093\/nar\/gkab293","volume":"49","author":"M Mancini","year":"2021","unstructured":"Mancini M, Magnani E, Macchi F, Bonapace IM. The multi-functionality of UHRF1: epigenome maintenance and preservation of genome integrity. Nucleic Acids Res. 2021;49:6053\u201368. https:\/\/doi.org\/10.1093\/nar\/gkab293.","journal-title":"Nucleic Acids Res"},{"key":"15091_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/nar\/gky975","volume":"47","author":"JY Hahm","year":"2019","unstructured":"Hahm JY, et al. Methylation of UHRF1 by SET7 is essential for DNA double-strand break repair. Nucleic Acids Res. 2019;47:184\u201396. https:\/\/doi.org\/10.1093\/nar\/gky975.","journal-title":"Nucleic Acids Res"},{"key":"15091_CR8","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.1038\/ncomms10201","volume":"7","author":"H Zhang","year":"2016","unstructured":"Zhang H, et al. A cell cycle-dependent BRCA1-UHRF1 cascade regulates DNA double-strand break repair pathway choice. Nat Commun. 2016;7:10201. https:\/\/doi.org\/10.1038\/ncomms10201.","journal-title":"Nat Commun"},{"key":"15091_CR9","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1038\/s41467-024-47314-4","volume":"15","author":"K Yamaguchi","year":"2024","unstructured":"Yamaguchi K, et al. Non-canonical functions of UHRF1 maintain DNA methylation homeostasis in cancer cells. Nat Commun. 2024;15:2960. https:\/\/doi.org\/10.1038\/s41467-024-47314-4.","journal-title":"Nat Commun"},{"key":"15091_CR10","doi-asserted-by":"publisher","first-page":"9053","DOI":"10.1093\/nar\/gkz626","volume":"47","author":"H Zhang","year":"2019","unstructured":"Zhang H, et al. SET8 prevents excessive DNA methylation by methylation-mediated degradation of UHRF1 and DNMT1. Nucleic Acids Res. 2019;47:9053\u201368. https:\/\/doi.org\/10.1093\/nar\/gkz626.","journal-title":"Nucleic Acids Res"},{"key":"15091_CR11","doi-asserted-by":"publisher","first-page":"1351908","DOI":"10.3389\/fimmu.2024.1351908","volume":"15","author":"L Liu","year":"2024","unstructured":"Liu L, et al. Integrated bioinformatics combined with machine learning to analyze shared biomarkers and pathways in psoriasis and cervical squamous cell carcinoma. Front Immunol. 2024;15:1351908. https:\/\/doi.org\/10.3389\/fimmu.2024.1351908.","journal-title":"Front Immunol"},{"key":"15091_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/15384101.2017.1403686","volume":"17","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Qiao L, Wang X, Ding C, Chen JJ. UHRF1 epigenetically down-regulates UbcH8 to inhibit apoptosis in cervical cancer cells. Cell Cycle. 2018;17:300\u20138. https:\/\/doi.org\/10.1080\/15384101.2017.1403686.","journal-title":"Cell Cycle"},{"key":"15091_CR13","doi-asserted-by":"publisher","first-page":"3966","DOI":"10.1038\/s41467-023-39591-2","volume":"14","author":"K Kostyrko","year":"2023","unstructured":"Kostyrko K, et al. UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. Nat Commun. 2023;14:3966. https:\/\/doi.org\/10.1038\/s41467-023-39591-2.","journal-title":"Nat Commun"},{"key":"15091_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.canlet.2020.08.008","volume":"493","author":"D Tian","year":"2020","unstructured":"Tian D, et al. Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy. Cancer Lett. 2020;493:80\u201390. https:\/\/doi.org\/10.1016\/j.canlet.2020.08.008.","journal-title":"Cancer Lett"},{"key":"15091_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41419-023-05895-w","volume":"14","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. UHRF1 inhibition epigenetically reprograms cancer stem cells to suppress the tumorigenic phenotype of hepatocellular carcinoma. Cell Death Dis. 2023;14:381. https:\/\/doi.org\/10.1038\/s41419-023-05895-w.","journal-title":"Cell Death Dis"},{"key":"15091_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/hep.30168","volume":"69","author":"M Barcena-Varela","year":"2019","unstructured":"Barcena-Varela M, et al. Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma. Hepatology. 2019;69:587\u2013603. https:\/\/doi.org\/10.1002\/hep.30168.","journal-title":"Hepatology"},{"key":"15091_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13578-024-01333-2","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, et al. SIRT6 deficiency impairs the deacetylation and ubiquitination of UHRF1 to strengthen glycolysis and lactate secretion in bladder cancer. Cell Biosci. 2024;14:153. https:\/\/doi.org\/10.1186\/s13578-024-01333-2.","journal-title":"Cell Biosci"},{"key":"15091_CR18","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/sj.bjc.6605123","volume":"101","author":"M Unoki","year":"2009","unstructured":"Unoki M, et al. UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer. Br J Cancer. 2009;101:98\u2013105. https:\/\/doi.org\/10.1038\/sj.bjc.6605123.","journal-title":"Br J Cancer"},{"key":"15091_CR19","doi-asserted-by":"publisher","first-page":"4929","DOI":"10.1096\/fj.13-233387","volume":"27","author":"L Zhou","year":"2013","unstructured":"Zhou L, et al. Regulation of UHRF1 by miR-146a\/b modulates gastric cancer invasion and metastasis. FASEB J. 2013;27:4929\u201339. https:\/\/doi.org\/10.1096\/fj.13-233387.","journal-title":"FASEB J"},{"key":"15091_CR20","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2024.2347757","volume":"16","author":"J Su","year":"2024","unstructured":"Su J, et al. Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation. Gut Microbes. 2024;16:2347757. https:\/\/doi.org\/10.1080\/19490976.2024.2347757.","journal-title":"Gut Microbes"},{"key":"15091_CR21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.ccell.2019.03.003","volume":"35","author":"X Kong","year":"2019","unstructured":"Kong X, et al. Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties. Cancer Cell. 2019;35:633-648 e637. https:\/\/doi.org\/10.1016\/j.ccell.2019.03.003.","journal-title":"Cancer Cell"},{"key":"15091_CR22","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13046-016-0308-0","volume":"35","author":"X Wan","year":"2016","unstructured":"Wan X, et al. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy. J Exp Clin Cancer Res. 2016;35:34. https:\/\/doi.org\/10.1186\/s13046-016-0308-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"15091_CR23","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1593\/neo.04112","volume":"6","author":"S Shukla","year":"2004","unstructured":"Shukla S, et al. Nuclear factor-kappaB\/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia. 2004;6:390\u2013400. https:\/\/doi.org\/10.1593\/neo.04112.","journal-title":"Neoplasia"},{"key":"15091_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002847","volume":"16","author":"AA Grosset","year":"2019","unstructured":"Grosset AA, et al. Validation of the prognostic value of NF-\u03baB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker Network. PLoS Med. 2019;16:e1002847. https:\/\/doi.org\/10.1371\/journal.pmed.1002847.","journal-title":"PLoS Med"},{"key":"15091_CR25","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1158\/1078-0432.CCR-06-0330","volume":"12","author":"L Lessard","year":"2006","unstructured":"Lessard L, et al. Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res. 2006;12:5741\u20135. https:\/\/doi.org\/10.1158\/1078-0432.CCR-06-0330.","journal-title":"Clin Cancer Res"},{"key":"15091_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/jcb.29856","volume":"122","author":"M Jadli","year":"2021","unstructured":"Jadli M, et al. Delineating role of NF-kappaB and interacting cytokines during prostate cancer-induced osteoclastogenesis. J Cell Biochem. 2021;122:259\u201376. https:\/\/doi.org\/10.1002\/jcb.29856.","journal-title":"J Cell Biochem"},{"key":"15091_CR27","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1038\/onc.2014.302","volume":"34","author":"R Jin","year":"2015","unstructured":"Jin R, et al. Inhibition of NF-kappa B signaling restores responsiveness of castrate-resistant prostate cancer cells to anti-androgen treatment by decreasing androgen receptor-variant expression. Oncogene. 2015;34:3700\u201310. https:\/\/doi.org\/10.1038\/onc.2014.302.","journal-title":"Oncogene"},{"key":"15091_CR28","doi-asserted-by":"publisher","first-page":"4828","DOI":"10.1038\/onc.2017.96","volume":"36","author":"J Yang","year":"2017","unstructured":"Yang J, et al. PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311. Oncogene. 2017;36:4828\u201342. https:\/\/doi.org\/10.1038\/onc.2017.96.","journal-title":"Oncogene"},{"key":"15091_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fcell.2019.00266","volume":"7","author":"Y Lin","year":"2019","unstructured":"Lin Y, et al. MiR-506 targets UHRF1 to inhibit colorectal cancer proliferation and invasion via the KISS1\/PI3K\/NF-kappaB signaling axis. Front Cell Dev Biol. 2019;7:266. https:\/\/doi.org\/10.3389\/fcell.2019.00266.","journal-title":"Front Cell Dev Biol"},{"key":"15091_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41389-022-00430-6","volume":"11","author":"SC Wu","year":"2022","unstructured":"Wu SC, et al. UHRF1 overexpression promotes osteosarcoma metastasis through altered exosome production and AMPK\/SEMA3E suppression. Oncogenesis. 2022;11:51. https:\/\/doi.org\/10.1038\/s41389-022-00430-6.","journal-title":"Oncogenesis"},{"key":"15091_CR31","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.canlet.2019.03.024","volume":"452","author":"Q Hu","year":"2019","unstructured":"Hu Q, et al. UHRF1 promotes aerobic glycolysis and proliferation via suppression of SIRT4 in pancreatic cancer. Cancer Lett. 2019;452:226\u201336. https:\/\/doi.org\/10.1016\/j.canlet.2019.03.024.","journal-title":"Cancer Lett"},{"key":"15091_CR32","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.3892\/ijo.2014.2813","volume":"46","author":"YD Jung","year":"2015","unstructured":"Jung YD, et al. Downregulation of UHRF1 promotes EMT via inducing CXCR4 in human cancer cells. Int J Oncol. 2015;46:1232\u201342. https:\/\/doi.org\/10.3892\/ijo.2014.2813.","journal-title":"Int J Oncol"},{"issue":"1","key":"15091_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3892\/mmr.2015.4515","volume":"13","author":"W Liu","year":"2016","unstructured":"Liu W, et al. UHRF1 promotes human osteosarcoma cell invasion by downregulating the expression of E\u2013cadherin in an Rb1\u2013dependent manner. Mol Med Rep. 2016;13(1):315\u201320. https:\/\/doi.org\/10.3892\/mmr.2015.4515.","journal-title":"Mol Med Rep"},{"key":"15091_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/cdd.2013.123","volume":"21","author":"E Sanchez-Tillo","year":"2014","unstructured":"Sanchez-Tillo E, et al. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. Cell Death Differ. 2014;21:247\u201357. https:\/\/doi.org\/10.1038\/cdd.2013.123.","journal-title":"Cell Death Differ"},{"key":"15091_CR35","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1245\/s10434-011-2194-1","volume":"19","author":"F Wang","year":"2012","unstructured":"Wang F, et al. UHRF1 promotes cell growth and metastasis through repression of p16(ink(4)a) in colorectal cancer. Ann Surg Oncol. 2012;19:2753\u201362. https:\/\/doi.org\/10.1245\/s10434-011-2194-1.","journal-title":"Ann Surg Oncol"},{"key":"15091_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/3758697","volume":"2022","author":"X Cui","year":"2022","unstructured":"Cui X, et al. Shmt2 drives the progression of colorectal cancer by regulating UHRF1 expression. Can J Gastroenterol Hepatol. 2022;2022:3758697. https:\/\/doi.org\/10.1155\/2022\/3758697.","journal-title":"Can J Gastroenterol Hepatol"},{"key":"15091_CR37","doi-asserted-by":"publisher","first-page":"e104252","DOI":"10.1371\/journal.pone.0104252","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. Upregulated UHRF1 promotes bladder cancer cell invasion by epigenetic silencing of KiSS1. PLoS ONE. 2014;9:e104252. https:\/\/doi.org\/10.1371\/journal.pone.0104252.","journal-title":"PLoS ONE"},{"key":"15091_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1590\/S1677-5538.IBJU.2016.0126","volume":"43","author":"S Saidi","year":"2017","unstructured":"Saidi S, Popov Z, Janevska V, Panov S. Overexpression of UHRF1 gene correlates with the major clinicopathological parameters in urinary bladder cancer. Int Braz J Urol. 2017;43:224\u20139. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2016.0126.","journal-title":"Int Braz J Urol"},{"key":"15091_CR39","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s12032-013-0613-9","volume":"30","author":"JT Pi","year":"2013","unstructured":"Pi JT, et al. Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma. Med Oncol. 2013;30:613. https:\/\/doi.org\/10.1007\/s12032-013-0613-9.","journal-title":"Med Oncol"},{"key":"15091_CR40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"key":"15091_CR41","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324:1029\u201333. https:\/\/doi.org\/10.1126\/science.1160809.","journal-title":"Science"},{"key":"15091_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.764","volume":"12","author":"CY Lin","year":"2022","unstructured":"Lin CY, et al. Inhibition of KDM4C\/c-Myc\/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism. Clin Transl Med. 2022;12:e764. https:\/\/doi.org\/10.1002\/ctm2.764.","journal-title":"Clin Transl Med"},{"key":"15091_CR43","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1158\/0008-5472.CAN-22-2433","volume":"83","author":"M Li","year":"2023","unstructured":"Li M, et al. LSD1 inhibition disrupts super-enhancer-driven oncogenic transcriptional programs in castration-resistant prostate cancer. Cancer Res. 2023;83:1684\u201398. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-2433.","journal-title":"Cancer Res"},{"key":"15091_CR44","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.apsb.2025.01.007","volume":"15","author":"X Zhang","year":"2025","unstructured":"Zhang X, et al. Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors. Acta Pharm Sin B. 2025;15:1415\u201329. https:\/\/doi.org\/10.1016\/j.apsb.2025.01.007.","journal-title":"Acta Pharm Sin B"},{"key":"15091_CR45","doi-asserted-by":"publisher","first-page":"3309","DOI":"10.1158\/0008-5472.CAN-09-3703","volume":"70","author":"N Nadiminty","year":"2010","unstructured":"Nadiminty N, et al. Aberrant activation of the androgen receptor by NF-kappaB2\/p52 in prostate cancer cells. Cancer Res. 2010;70:3309\u201319. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-3703.","journal-title":"Cancer Res"},{"key":"15091_CR46","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2353\/ajpath.2009.080727","volume":"175","author":"L Zhang","year":"2009","unstructured":"Zhang L, et al. NF-kappaB regulates androgen receptor expression and prostate cancer growth. Am J Pathol. 2009;175:489\u201399. https:\/\/doi.org\/10.2353\/ajpath.2009.080727.","journal-title":"Am J Pathol"},{"key":"15091_CR47","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1158\/0008-5472.CAN-13-2543","volume":"74","author":"R Jin","year":"2014","unstructured":"Jin R, et al. NF-kappaB gene signature predicts prostate cancer progression. Cancer Res. 2014;74:2763\u201372. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2543.","journal-title":"Cancer Res"},{"key":"15091_CR48","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1093\/nar\/gkz108","volume":"47","author":"Z Shang","year":"2019","unstructured":"Shang Z, et al. LncRNA PCAT1 activates AKT and NF-kappaB signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKKalpha complex. Nucleic Acids Res. 2019;47:4211\u201325. https:\/\/doi.org\/10.1093\/nar\/gkz108.","journal-title":"Nucleic Acids Res"},{"key":"15091_CR49","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12935-021-01897-w","volume":"21","author":"M Jin","year":"2021","unstructured":"Jin M, et al. Feedback activation of NF-KB signaling leads to adaptive resistance to EZH2 inhibitors in prostate cancer cells. Cancer Cell Int. 2021;21:191. https:\/\/doi.org\/10.1186\/s12935-021-01897-w.","journal-title":"Cancer Cell Int"},{"key":"15091_CR50","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1692","volume":"14","author":"X Guan","year":"2024","unstructured":"Guan X, et al. Inhibition of HDAC2 sensitises antitumour therapy by promoting NLRP3\/GSDMD-mediated pyroptosis in colorectal cancer. Clin Transl Med. 2024;14:e1692. https:\/\/doi.org\/10.1002\/ctm2.1692.","journal-title":"Clin Transl Med"},{"key":"15091_CR51","doi-asserted-by":"publisher","first-page":"156405","DOI":"10.1016\/j.phymed.2025.156405","volume":"138","author":"T Zhang","year":"2025","unstructured":"Zhang T, et al. Modified Shenqi Dihuang decoction inhibits prostate cancer metastasis by disrupting TCA cycle energy metabolism via NF-kB\/p65-mediated OGDH regulation. Phytomedicine. 2025;138:156405. https:\/\/doi.org\/10.1016\/j.phymed.2025.156405.","journal-title":"Phytomedicine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15091-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15091-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T21:03:04Z","timestamp":1762290184000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15091-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15091"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15091-y","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"7 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Zhejiang Cancer Hospital. Ethics approval number is IRB-2025-34 (IIT). Written informed consent was secured from all patients prior to surgical intervention.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1697"}}